BackAdamas Pharmaceuticals Overview

Adamas Pharmaceuticals EBIT

EBIT (Earnings Before Interest and Taxes) analysis for ADMS.

Quarterly EBIT

-$5.64M
↑ 35.7% YoY

As of Sep 30, 2021

Annual EBIT (TTM)

-$39.29M
↑ 19.39% YoY

Trailing 12 months ending Sep 30, 2021

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin